Grey Wolf Health Corp. (TSXV:WOLF)

Canada · Delayed Price · Currency is CAD

1.750

+0.020 (1.16%)

Sep 30, 2026, 3:54 PM EST

Market Cap	59.93M +35.9%
Revenue (ttm)	37.65M +21.3%
Net Income	1.53M +95.8%
EPS	0.04 +87.5%
Shares Out	34.64M
PE Ratio	38.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	101,600
Open	1.700
Previous Close	1.730
Day's Range	1.700 - 1.750
52-Week Range	1.160 - 1.850
Beta	0.46
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About Grey Wolf Health

Grey Wolf Health Corp. operates as an animal health and wellness company in Canada. The company operates in two segments, Animal Health Business Unit and Pharmacy Business Unit. It engages in the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics, as well as offers pharmaceuticals for the human and animal health markets. The company provides dexmedetomidine hydrochloride oromucosal gel under the SILEO name; sedative analgesic and reversing agents for companion animals under the SEDA... [Read more]

Industry Pharmaceutical Retailers

Sector Healthcare

CEO Angela Cechetto

Employees 40

Stock Exchange TSX Venture Exchange

Ticker Symbol WOLF

Full Company Profile

Financial Performance

In 2025, Grey Wolf Health's revenue was 35.76 million, an increase of 33.30% compared to the previous year's 26.83 million. Earnings were 1.66 million, an increase of 135.11%.

Financial Statements